Tego Science acquires approval of ‘ROSMIR,’ Korea’s first cell treatment for wrinkle enhancement

Tego Science(CEO Sae-Hwa Jeon) announced on the 28^th that ROSMIR®(project name: TPX-105), an autologous wrinkle reducer, from the Ministry of Food and Drug Safety. With this, Tego Science now owns the highest number of cell therapies only in Korea, but the world.

Meaning ‘dew of miracle’ in Spanish, ROSMIR, the TPX-105’s official name, is the world’s first cell therapy which reduces under-eye ...